Skip to Content

Notice

Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 10A63, 11601 Landsdown St., North Bethesda, MD 20852, PRAStaff@fda.hhs.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the Internet at http://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

Table 1—List of Information Collections Approved by OMB

Title of collectionOMB control No.Date approval expires
Investigational New Drug Regulations0910-00142/28/2019
Start Printed Page 52879
Guidance for Industry on Formal Dispute Resolutions; Appeals Above the Division Level0910-04302/28/2019
SPF Labeling and Testing Requirements for OTC Sunscreen Products0910-07172/28/2019
Generic Drug User Fee Cover Sheet—Form FDA 37940910-07272/28/2019
Environmental Impact Considerations0910-03224/30/2019
FDA Adverse Event Reports; Electronic Submissions0910-06455/31/2019
Importer's Entry Notice0910-00466/30/2019
Exports: Notification and Recordkeeping Requirements0910-04826/30/2019
Focused Mitigation Strategies to Protect Food Against Intentional Adulteration0910-08126/30/2019
Start Signature

Dated: August 5, 2016.

Jeremy Sharp,

Deputy Commissioner for Policy, Planning, Legislation, and Analysis.

End Signature End Supplemental Information

[FR Doc. 2016-19021 Filed 8-9-16; 8:45 am]

BILLING CODE 4164-01-P